[11C]Epinephrine

[11C]Epinephrine

SCHEMBL29371663

[11CH3]NC[C@H](O)c1ccc(O)c(O)c1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3

The experimentally established mechanism targets of [11C]Epinephrine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRB2 known ✓ P07550 7/20 1.00
ADRB1 known ✓ P08588 6/20 1.00
ADRB3 known ✓ P13945 5/20 1.00
ADRA2A known ✓ P08913 3/20 1.00
ADRA2B known ✓ P18089 3/20 1.00
ADRA2C known ✓ P18825 3/20 1.00
ADRA1A known ✓ P35348 3/20 1.00
ADRA1B known ✓ P35368 3/20 1.00
ADRA1D known ✓ P25100 2/20 1.00
KDM4E B2RXH2 8/20 1.00
TDP1 Q9NUW8 7/20 1.00
HIF1A Q16665 7/20 1.00
MAPT P10636 6/20 1.00
HSD17B10 Q99714 6/20 1.00
TSHR P16473 5/20 1.00
CYP1A2 P05177 4/20 1.00
MEN1 O00255 3/20 1.00
KMT2A Q03164 3/20 1.00
MTOR P42345 3/20 1.00
MAPK1 P28482 3/20 1.00

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Racepinephrine SCHEMBL29396039 1.00 KDM4E (1.00) KDM4ETDP1ADRB2HIF1AMAPT
[11C]Epinephrine SCHEMBL29374823 1.00 KDM4E (1.00) KDM4ETDP1ADRB2HIF1AMAPT
Epinephrine SCHEMBL29353423 1.00 KDM4E (1.00) KDM4ETDP1ADRB2HIF1AMAPT
L-Adrenaline SCHEMBL29519331 1.00 KDM4E (1.00) KDM4ETDP1ADRB2HIF1AMAPT
Epinephrine SCHEMBL2837188 1.00 KDM4E (1.00) KDM4ETDP1ADRB2HIF1AMAPT
Racepinephrine SCHEMBL11631789 1.00 KDM4E (1.00) KDM4ETDP1ADRB2HIF1AMAPT
L-Adrenaline SCHEMBL11647 1.00 KDM4E (1.00) KDM4ETDP1ADRB2HIF1AMAPT
Racepinephrine SCHEMBL3815 1.00 KDM4E (1.00) KDM4ETDP1ADRB2HIF1AMAPT
Racepinephrine SCHEMBL20493843 1.00 KDM4E (1.00) KDM4ETDP1ADRB2HIF1AMAPT
Epinephrine SCHEMBL8576894 1.00 KDM4E (1.00) KDM4ETDP1ADRB2HIF1AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12324845-B2 Ligands for imaging cardiac innervation LANTHEUS MEDICAL IMAGING, INC. (US) 2025-06-10 US disclosed
US-20250161500-A1 LIGANDS FOR IMAGING CARDIAC INNERVATION LANTHEUS MEDICAL IMAGING, INC. (US) 2025-05-22 US disclosed
US-20220288243-A1 LIGANDS FOR IMAGING CARDIAC INNERVATION LANTHEUS MEDICAL IMAGING, INC. (US) 2022-09-15 US disclosed
US-11241509-B2 Ligands for imaging cardiac innervation LANTHEUS MEDICAL IMAGING, INC. (US) 2022-02-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220288243-A1 LIGANDS FOR IMAGING CARDIAC INNERVATION TNNT2, PNMT, TNNC1 ADRB2 8/4885ADRB1 7/4885ADRB3 6/4885
US-11241509-B2 Ligands for imaging cardiac innervation TNNT2, PNMT, TNNC1 ADRB2 10/4885ADRB1 7/4885ADRB3 6/4885
US-20250161500-A1 LIGANDS FOR IMAGING CARDIAC INNERVATION TNNT2, PNMT, TNNC1 ADRB2 8/4885ADRB1 7/4885ADRB3 6/4885
US-12324845-B2 Ligands for imaging cardiac innervation CHRNB4, RXFP4, RXFP3 ADRB2 41/4885ADRB1 35/4885ADRB3 8/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.